口腔癌及口咽癌病理诊断规范

2020-07-30 中华口腔医学会 中国口腔颌面外科杂志.2020.18(4):289-296.

口腔癌及口咽癌是口腔领面部最常见的恶性肿瘤。规范化的口腔癌及口咽癌病理诊断报告不仅应提供给临床准确的病理诊断,还应包括与患者预后评估、治疗策略选择相关的信息。由中华口腔医学会门腔病理学专业委员会牵头组

中文标题:

口腔癌及口咽癌病理诊断规范

发布机构:

中华口腔医学会

发布日期:

2020-07-30

简要介绍:

口腔癌及口咽癌是口腔领面部最常见的恶性肿瘤。规范化的口腔癌及口咽癌病理诊断报告不仅应提供给临床准确的病理诊断,还应包括与患者预后评估、治疗策略选择相关的信息。由中华口腔医学会门腔病理学专业委员会牵头组织成立专家组,对n腔癌及门咽癌病理标本固定、取材及报告内容等进行研讨与规范,形成《门腔癌及门咽癌病理诊断规范》。此规范涵盖了近年来在口腔癌和口咽癌临床病理方面的一些重要变化,如n腔癌肿瘤T分期应考虑肿瘤侵袭深度、肿瘤N分期应考虑有无淋巴结外扩展、口咽癌中新亚型人乳头状瘤病毒相关性鳞状细胞癌等。希望通过本规范的制定,提高我国口腔癌及口咽癌病理报告质量,为临床治疗及预后评估提供依据。

相关资料下载:
[AttachmentFileName(sort=1, fileName=口腔癌及口咽癌病理诊断规范_李江.pdf)] GetToolGuiderByIdResponse(projectId=1, id=00d771c00199603f, title=口腔癌及口咽癌病理诊断规范, enTitle=, guiderFrom=中国口腔颌面外科杂志.2020.18(4):289-296., authorId=0, author=, summary=口腔癌及口咽癌是口腔领面部最常见的恶性肿瘤。规范化的口腔癌及口咽癌病理诊断报告不仅应提供给临床准确的病理诊断,还应包括与患者预后评估、治疗策略选择相关的信息。由中华口腔医学会门腔病理学专业委员会牵头组, cover=https://img.medsci.cn/20201024/1603468903393_2020535.jpg, journalId=0, articlesId=null, associationId=232, associationName=中华口腔医学会, associationIntro=中华口腔医学会是口腔医学科学技术工作者自愿结成的全国性学术性群众团体,为非营利性社会组织,是依法成立的社团法人,是政府联系口腔医学科学技术工作者的纽带和桥梁,是发展我国口腔医学科学的社会力量。学会成立于1996年11月7日,她的前身是1951年成立的中华医学会口腔科学会。 学会成立以来,全国各省市的口腔分会亦争取从省、直辖市医学会中独立出来,成立省、直辖市口腔医学会。省市口腔医学会一成立即成为中华口腔医学会的团体会员,除对学会有业务指导关系外,尚的对团体会员的领导作用。, copyright=0, guiderPublishedTime=Thu Jul 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>口腔癌及口咽癌是口腔领面部最常见的恶性肿瘤。规范化的口腔癌及口咽癌病理诊断报告不仅应提供给临床准确的病理诊断,还应包括与患者预后评估、治疗策略选择相关的信息。由中华口腔医学会门腔病理学专业委员会牵头组织成立专家组,对n腔癌及门咽癌病理标本固定、取材及报告内容等进行研讨与规范,形成《门腔癌及门咽癌病理诊断规范》。此规范涵盖了近年来在口腔癌和口咽癌临床病理方面的一些重要变化,如n腔癌肿瘤T分期应考虑肿瘤侵袭深度、肿瘤N分期应考虑有无淋巴结外扩展、口咽癌中新亚型人乳头状瘤病毒相关性鳞状细胞癌等。希望通过本规范的制定,提高我国口腔癌及口咽癌病理报告质量,为临床治疗及预后评估提供依据。</p> </div> </div> </div>, tagList=[TagDto(tagId=4850, tagName=口腔癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=31, categoryName=口腔科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=4850, guiderKeyword=口腔癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=14233, appHits=221, showAppHits=0, pcHits=1188, showPcHits=14012, likes=0, shares=13, comments=11, approvalStatus=1, publishedTime=Sat Oct 24 00:09:27 CST 2020, publishedTimeString=2020-07-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Oct 24 00:01:50 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 17:09:37 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=口腔癌及口咽癌病理诊断规范_李江.pdf)])
口腔癌及口咽癌病理诊断规范_李江.pdf
下载请点击:
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1008529, encodeId=61aa10085292d, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b14e3079593, createdName=1807862921, createdTime=Tue Aug 17 01:41:43 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008392, encodeId=9518100839261, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2eb45574558, createdName=Clairvoyant_zyy, createdTime=Mon Aug 16 17:44:47 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970645, encodeId=37a29e0645a9, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4aff5512769, createdName=开普勒, createdTime=Thu Jun 03 17:41:26 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919995, encodeId=9a0d919995cd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c85a5455952, createdName=ms6000001089246956, createdTime=Tue Jan 26 13:38:37 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902346, encodeId=0207902346e3, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61415438582, createdName=ms5000000317202262, createdTime=Thu Nov 26 01:19:55 CST 2020, time=2020-11-26, status=1, ipAttribution=)]
    2021-08-17 1807862921

    good

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1008529, encodeId=61aa10085292d, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b14e3079593, createdName=1807862921, createdTime=Tue Aug 17 01:41:43 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008392, encodeId=9518100839261, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2eb45574558, createdName=Clairvoyant_zyy, createdTime=Mon Aug 16 17:44:47 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970645, encodeId=37a29e0645a9, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4aff5512769, createdName=开普勒, createdTime=Thu Jun 03 17:41:26 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919995, encodeId=9a0d919995cd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c85a5455952, createdName=ms6000001089246956, createdTime=Tue Jan 26 13:38:37 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902346, encodeId=0207902346e3, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61415438582, createdName=ms5000000317202262, createdTime=Thu Nov 26 01:19:55 CST 2020, time=2020-11-26, status=1, ipAttribution=)]
    2021-08-16 Clairvoyant_zyy

    不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1008529, encodeId=61aa10085292d, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b14e3079593, createdName=1807862921, createdTime=Tue Aug 17 01:41:43 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008392, encodeId=9518100839261, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2eb45574558, createdName=Clairvoyant_zyy, createdTime=Mon Aug 16 17:44:47 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970645, encodeId=37a29e0645a9, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4aff5512769, createdName=开普勒, createdTime=Thu Jun 03 17:41:26 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919995, encodeId=9a0d919995cd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c85a5455952, createdName=ms6000001089246956, createdTime=Tue Jan 26 13:38:37 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902346, encodeId=0207902346e3, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61415438582, createdName=ms5000000317202262, createdTime=Thu Nov 26 01:19:55 CST 2020, time=2020-11-26, status=1, ipAttribution=)]
    2021-06-03 开普勒

    不错

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1008529, encodeId=61aa10085292d, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b14e3079593, createdName=1807862921, createdTime=Tue Aug 17 01:41:43 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008392, encodeId=9518100839261, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2eb45574558, createdName=Clairvoyant_zyy, createdTime=Mon Aug 16 17:44:47 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970645, encodeId=37a29e0645a9, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4aff5512769, createdName=开普勒, createdTime=Thu Jun 03 17:41:26 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919995, encodeId=9a0d919995cd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c85a5455952, createdName=ms6000001089246956, createdTime=Tue Jan 26 13:38:37 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902346, encodeId=0207902346e3, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61415438582, createdName=ms5000000317202262, createdTime=Thu Nov 26 01:19:55 CST 2020, time=2020-11-26, status=1, ipAttribution=)]
    2021-01-26 ms6000001089246956

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1008529, encodeId=61aa10085292d, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b14e3079593, createdName=1807862921, createdTime=Tue Aug 17 01:41:43 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008392, encodeId=9518100839261, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2eb45574558, createdName=Clairvoyant_zyy, createdTime=Mon Aug 16 17:44:47 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970645, encodeId=37a29e0645a9, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4aff5512769, createdName=开普勒, createdTime=Thu Jun 03 17:41:26 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=919995, encodeId=9a0d919995cd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c85a5455952, createdName=ms6000001089246956, createdTime=Tue Jan 26 13:38:37 CST 2021, time=2021-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902346, encodeId=0207902346e3, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=61415438582, createdName=ms5000000317202262, createdTime=Thu Nov 26 01:19:55 CST 2020, time=2020-11-26, status=1, ipAttribution=)]
    2020-11-26 ms5000000317202262

    不错

    0

拓展阅读

2014 USPSTF建议声明:口腔癌的筛查

美国预防医学工作组(USPSTF,U.S. Preventive Services Task Force) · 2014-01-07

2019 KSTHNS指南:口腔癌的手术治疗

韩国甲状腺头颈部外科学会(KSTHNS,Korean Society of Thyroid-Head and Neck Surgery) · 2019-02-02

2018 外科共识指南:口腔癌患者前哨淋巴结活检

国外肿瘤科相关专家小组(统称) · 2019-03-21

口腔癌合并全身系统性疾病患者的多学科协作诊疗模式专家共识

中国口腔科相关专家组(统称) · 2020-12-02

2023 SSOS 临床实践指南:口腔癌患者口腔护理

西班牙口腔外科学会 SSOS the spanish society of oral surgery · 2023-05-22